Dynamic Technology Lab Private Ltd Buys New Holdings in TriMas Co. (NASDAQ:TRS)

TriMas logo Dynamic Technology Lab Private Ltd bought a new position in shares of TriMas Co. (NASDAQ:TRS – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 21,030 shares of the industrial products company’s stock, valued at approximately $533,000. Dynamic Technology Lab Private Ltd owned approximately 0.05% of TriMas as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of TriMas by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 4,215,033 shares of the industrial products company’s stock valued at $104,364,000 after acquiring an additional 34,517 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in shares of TriMas by 16.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,069,777 shares of the industrial products company’s stock valued at $77,757,000 after buying an additional 422,717 shares during the period. Pzena Investment Management LLC grew its position in shares of TriMas by 7.0% during the 3rd quarter. Pzena Investment Management LLC now owns 2,570,194 shares of the industrial products company’s stock valued at $63,638,000 after buying an additional 167,452 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in TriMas by 2.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,513,479 shares of the industrial products company’s stock worth $63,667,000 after acquiring an additional 51,030 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in TriMas by 4.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 537,981 shares of the industrial products company’s stock worth $13,627,000 after acquiring an additional 20,956 shares during the last quarter. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Thomas A. Amato purchased 10,000 shares of the business’s stock in a transaction dated Friday, March 1st. The shares were acquired at an average price of $23.62 per share, for a total transaction of $236,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 286,168 shares of the company’s stock, valued at $6,759,288.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CFO Scott A. Mell sold 1,500 shares of the stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $27.30, for a total transaction of $40,950.00. Following the completion of the sale, the chief financial officer now directly owns 31,923 shares in the company, valued at $871,497.90. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Thomas A. Amato acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The stock was acquired at an average price of $23.62 per share, with a total value of $236,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 286,168 shares of the company’s stock, valued at approximately $6,759,288.16. The disclosure for this purchase can be found here. Insiders have purchased 25,681 shares of company stock worth $647,113 in the last three months. 1.10% of the stock is currently owned by insiders.

TriMas Trading Up 1.0 %

Shares of NASDAQ:TRS opened at $27.10 on Friday. The company has a quick ratio of 1.41, a current ratio of 2.73 and a debt-to-equity ratio of 0.63. The company’s 50-day moving average price is $26.32 and its 200 day moving average price is $25.44. The company has a market cap of $1.10 billion, a PE ratio of 27.94 and a beta of 0.71. TriMas Co. has a fifty-two week low of $22.59 and a fifty-two week high of $29.07.

TriMas (NASDAQ:TRS – Get Free Report) last released its earnings results on Tuesday, April 30th. The industrial products company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. The firm had revenue of $227.10 million for the quarter, compared to analysts’ expectations of $220.60 million. TriMas had a net margin of 4.48% and a return on equity of 9.68%. TriMas’s quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the company earned $0.30 EPS. Sell-side analysts anticipate that TriMas Co. will post 2 earnings per share for the current year.

TriMas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 14th. Stockholders of record on Tuesday, May 7th were given a dividend of $0.04 per share. The ex-dividend date of this dividend was Monday, May 6th. This represents a $0.16 annualized dividend and a dividend yield of 0.59%. TriMas’s dividend payout ratio (DPR) is 16.49%.

Analyst Upgrades and Downgrades

Separately, BWS Financial reiterated a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday, May 1st.

Read Our Latest Stock Analysis on TriMas

About TriMas

(Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Daily News